Clinical Trial Update: Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients [Phase 2]

View source ↗

Summary

Phase II interventional trial evaluating the efficacy and safety of secukinumab in active severe Takayasu arteritis with large vessel vasculitis; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Vessel Vasculitis
• Takayasu Arteritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Takayasu Arteritis, Large Vessel Vasculitis | Phase 2 | Status: NOT_YET_RECRUITING